Evidence map›Paper›PMID 32330225›Full record

ArticleBioinformatics (Oxford, England)2020

Predicting target genes of non-coding regulatory variants with IRT.

Zhenqin Wu, Nilah M Ioannidis, James Zou

Open access · greenAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Zhenqin WuDepartment of Chemistry, Stanford University, CA 94305, USA.
Nilah M IoannidisDepartment of Biomedical Data Science, Stanford University School of Medicine, Stanford, 94305 CA, USA.
James ZouDepartment of Biomedical Data Science, Stanford University School of Medicine, Stanford, 94305 CA, USA.
Stanford University · USChan Zuckerberg Initiative (United States) · US

Funding

Stanford Medicine Center for Longevity and Healthy Aging Research Education CoreP30AG059307 · NIA · STANFORD UNIVERSITY · PI PERIYAKOIL, VYJEYANTHI S · 2018 to 2025
$4.9M
Statistical Methods for Personal Genome InterpretationR00HG009677 · NHGRI · UNIVERSITY OF CALIFORNIA BERKELEY · PI IOANNIDIS, NILAH MONNIER · 2019 to 2021
$634k
Developing data tools to reduce CVD disparities via Health Information ExchangesR21MD012867 · NIMHD · STANFORD UNIVERSITY · PI ZOU, JAMES · 2018 to 2019
$420k
Statistical methods for personal genome interpretation: genome variation, transcriptome variation, and their combined effects on complex traitsK99HG009677 · NHGRI · STANFORD UNIVERSITY · PI IOANNIDIS, NILAH MONNIER · 2017 to 2018
$347k
NHGRI NIH HHS K99 HG009677NHGRI NIH HHS R00 HG009677NIA NIH HHS P30 AG059307NIMHD NIH HHS R21 MD012867
6 · The paper itself

Abstract

summaryInterpreting genetic variants of unknown significance (VUS) is essential in clinical applications of genome sequencing for diagnosis and personalized care. Non-coding variants remain particularly difficult to interpret, despite making up a large majority of trait associations identified in genome-wide association studies (GWAS) analyses. Predicting the regulatory effects of non-coding variants on candidate genes is a key step in evaluating their clinical significance. Here, we develop a machine-learning algorithm, Inference of Connected expression quantitative trait loci (eQTLs) (IRT), to predict the regulatory targets of non-coding variants identified in studies of eQTLs. We assemble datasets using eQTL results from the Genotype-Tissue Expression (GTEx) project and learn to separate positive and negative pairs based on annotations characterizing the variant, gene and the intermediate sequence. IRT achieves an area under the receiver operating characteristic curve (ROC-AUC) of 0.799 using random cross-validation, and 0.700 for a more stringent position-based cross-validation. Further evaluation on rare variants and experimentally validated regulatory variants shows a significant enrichment in IRT identifying the true target genes versus negative controls. In gene-ranking experiments, IRT achieves a top-1 accuracy of 50% and top-3 accuracy of 90%. Salient features, including GC-content, histone modifications and Hi-C interactions are further analyzed and visualized to illustrate their influences on predictions. IRT can be applied to any VUS of interest and each candidate nearby gene to output a score reflecting the likelihood of regulatory effect on the expression level. These scores can be used to prioritize variants and genes to assist in patient diagnosis and GWAS follow-up studies. AVAILABILITY AND IMPLEMENTATION: Codes and data used in this work are available at https://github.com/miaecle/eQTL_Trees. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

Genome-Wide Association StudyQuantitative Trait LociChromosome MappingHistone CodeHumansPhenotypePolymorphism, Single Nucleotide

Identifiers

PMID32330225
PMCPMC7575052
OpenAlexW3019163011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.